Crux Biolabs
Bayswater, Australia cruxbiolabs.com From their website, Nov 2026
- ISO 17025
Work here? Claim this listing
About
Crux Biolabs provides bioanalytical services for clinical research and clinical development. It supports sponsors with pharmacokinetic, biomarker, immunogenicity, cellular, and sample-processing work from its Melbourne-based team in Victoria, Australia, with global flow-cytometry support through partner laboratories in the United States and Europe.
Services
Small Molecule PK
LC-MS/MS bioanalysis for quantitative pharmacokinetic and pharmacodynamic measurement of small molecules and related analytes in biological matrices.
Large Molecule PK
Ligand binding assays for quantitative pharmacokinetic assessment of biologics such as monoclonal antibodies, bispecific antibodies, and recombinant proteins.
Cell Therapy PK
Flow-cytometry-based assays to support cellular pharmacokinetic assessment alongside pharmacodynamic, target-engagement, and receptor-occupancy endpoints for applicable modalities.
Pharmacodynamics (PD)
Bioanalytical support for pharmacodynamic assessment using cellular assays, flow cytometry, LC-MS/MS, and biomarker analysis.
Immunogenicity (ADA)
Anti-drug antibody testing with screening, confirmatory, titration, and neutralising-antibody assays for clinical immunogenicity assessment.
Biomarker Analysis
Biomarker testing and analysis using established ligand binding and LC-MS/MS platforms, with custom method development when needed.
Flow Cytometry
Spectral flow cytometry services for immune-cell phenotyping, receptor occupancy, target engagement, vaccine response, and biomarker assessment.
Cellular Immunology and Functional Assays
Cell-based assays including proliferation, viability, inhibition, stimulation, cytotoxicity, cytokine release, and cell-mediated immunity assays.
4 more services
- PBMC and Laboratory Services
- LC-MS/MS bioanalysis
- Ligand binding assays
- Sample storage and shipment
Capabilities
- Assays and studies
- Bioanalysis
- Flow cytometry
- Immunogenicity
- Small molecules
- PK/PD
- Cell therapy
21 more
- LC-MS/MS
- HPLC
- Antibodies
- Bispecifics
- Ligand binding assay
- Electrochemiluminescence
- ELISA
- Multiplex bead-array assay
- Spectral flow cytometry
- ADA screening
- Confirmatory assay
- ADA titration
- Neutralising-antibody assay
- Proliferation assay
- Viability assay
- Inhibition assay
- Stimulation assay
- Cytotoxicity assay
- Ligand binding assay (LBA)
- Electrochemiluminescence (ECL)
- Cell-mediated immunity assays
- Scale and capacity
- Up to 40 parameters in a single flow-cytometry run
- Up to 40 parameters in a single run
- Therapeutic areas
- Vaccines
- Infectious diseases
- Oncology
- Metabolic diseases
- Inflammatory diseases
- Autoimmune diseases
- Immuno-oncology
Instruments and platforms
- Agilent LC-MS/MS
- UHPLC
- Cytek Aurora 5-laser spectral flow cytometry
- Meso Scale Discovery (MSD) electrochemiluminescence platforms
- Meso Scale Discovery (MSD)
Modalities and species
- Modalities
- Small molecule
- Antibody
- Bispecific
- Cell therapy
- Recombinant protein
- Vaccine
- Species and models
- PBMCs
- BMMCs
- Primary cells
- Cell lines
- CAR-T cells
Certifications
As the company states them, with the certificate or registry record where there is one.
ISO/IEC 17025:2017Self-reported
Scope: defined bioanalytical activities
Details
- Type
- CRO
- Address
- 885 Mountain Highway, Bayswater, Victoria, 3153, Australia
- Sites
- Bayswater, Victoria, Australia
- Melbourne, Australia
- Serves
- Australia, United States, Europe, APAC, global clinical programs